Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.25.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands
3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Condensed Consolidated Statements of Operations and Comprehensive Loss    
Revenue $ 100,000 $ 0
Operating expenses:    
Research and development 3,550,000 1,305,000
General and administrative 2,501,000 2,801,000
Total operating expenses 6,051,000 4,106,000
Operating loss (5,951,000) (4,106,000)
Other income (expense):    
Interest income 267,000 174,000
Interest expense (36,000) (57,000)
Total other income 231,000 117,000
Net loss (5,720,000) (3,989,000)
Other comprehensive loss - unrealized loss on debt securities (15,000)  
Comprehensive loss $ (5,735,000) $ (3,989,000)
Loss per common share - basic $ (0.11) $ (0.46)
Loss per common share - diluted $ (0.11) $ (0.46)
Weighted-average common shares outstanding - basic 52,981 8,633
Weighted-average common shares outstanding - diluted 52,981 8,633